Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diuretic plus angiotensin receptor antagonist versus diuretic monotherapy for hypertension
RBR-2cnzk7Phase 3Not yet recruiting
- Sponsor
- HCor
- Start
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of indapamide and losartan in hypertension (HTN) (3 arms), sponsored by HCor. Planned start Dec 2015; status: not yet recruiting.
02
Drugs
indapamidelosartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on RBR-2cnzk7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-2cnzk7.